DLH Holdings Corp(DLHC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 5:23 PM ET (Korea 9/12 06:23)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.49 | Insider Own | 13.99% | Shs Outstand | 14.5M | Perf Week | -4.61% |
| Market Cap | 0.06B | Forward P/E | - | EPS next Y | 9.21% | Insider Trans | 10.98% | Shs Float | 12.5M | Perf Month | -15.94% |
| Enterprise Value | 0.20B | PEG | - | EPS next Q | -0.28 | Inst Own | 70.02% | Short Float | 0.55% | Perf Quarter | -28.8% |
| Income | -0.02B | P/S | 0.22 | EPS this Y | -944.44% | Inst Trans | 2.33% | Short Ratio | 1.26 | Perf Half Y | -34.17% |
| Sales | 0.25B | P/B | 0.61 | EPS next 5Y | - | ROA | -7.78% | Short Interest | 0.07M | Perf YTD | -30.44% |
| Book/sh | 6.44 | P/C | 247.65 | EPS past 3/5Y | -61.44% -29.55% | ROE | -20.84% | 52W High | -51.48% ($8.10) | Perf Year | -28.55% |
| Cash/sh | 0.02 | P/FCF | 4.12 | Sales past 3/5Y | -4.47% 10.49% | ROIC | -10.26% | 52W Low | 3.83% ($3.79) | Perf 3Y | -65.65% |
| Dividend Est. | - | EV/EBITDA | 11.9 | EPS Y/Y TTM | -564.69% | Gross Margin | 11.29% | Volatility(W/M) | 4.96% 3.45% | Perf 5Y | -66.95% |
| Dividend TTM | - | EV/Sales | 0.78 | Sales Y/Y TTM | -29.52% | Oper. Margin | -0.11% | ATR (14) | 0.17 | Perf 10Y | -16.38% |
| Dividend Ex-Date | - | Quick Ratio | 0.67 | EPS Q/Q | -5891.5% | Profit Margin | -8.51% | RSI (14) | 28.56 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.67 | Sales Q/Q | -46.94% | SMA20 | -9.1% ($4.32) | Beta | 1.51 | Target Price | $7 |
| Payout | - | Debt/Eq | 1.51 | Earnings | 2026/7/29 | SMA50 | -17.9% ($4.79) | Rel Volume | 0.18 | Prev Close | $4.01 |
| Employees | 2300 | LT Debt/Eq | 1.25 | EPS/Sales Surpr. | -582.35% -11.6% | SMA200 | -28.7% ($5.51) | Avg Volume(3M) | 0.05M | Price | $3.93 |
| IPO | 1986/5/15 | Option/Short | Yes/Yes | Trades | 114 | Volume | 9,538 | Change | -2% |
Company
DLHC is a Industrials sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A public sector services company that provides technology-driven healthcare and defense readiness solutions to U.S. federal government agencies. By combining capabilities in AI, cybersecurity, and clinical research, the company supports the Department of Health and Human Services (HHS), the Department of Veterans Affairs (VA), and the Department of Defense (DoD) in addressing complex national priorities.
Over the past 1 year, on the lower side
51% below its 1-year high.
DLHC has weak earning power
Review management risk carefully before investing
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -944.4% this year.
Tap to view numbers
The stock looks undervalued
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -65.7% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 70.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IWC 0.00%
AVTM 0.00%
DFAS 0.00%
DFAT 0.00%
DFSV 0.00%It ranks #4 in the industry
Based on market cap of $57M.
DLHC $57M PER -
CTAS $81B PER 41.0
RELX $59B PER 20.2
TRI $42B PER 26.1
FAQ
What kind of company is DLHC?
DLHC belongs to the Industrials sector and operates in the Specialty Business Services industry.
What is the market cap of DLHC?
The market cap of DLHC is approximately $57M, ranking 4,894 within its sector.
What is the 52-week high and low for DLHC?
DLHC has recorded a 52-week high of $8.10 and a low of $3.79.
